We are live on
!
Find out more
PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
1-Year Est. Return
3.35%
This Fund
S&P 500
This Quarter
Est. Return
+39.14%
1 Year Est. Return
+3.35%
3 Year Est. Return
+113.14%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$197M
AUM Growth
–
Cap. Flow
+$177M
Cap. Flow
% of AUM
89.82%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
6
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
IMDZ
Immune Design Corp.
IMDZ
|
+$74.9M |
| 2 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$60.5M |
| 3 |
AGRX
Agile Therapeutics
AGRX
|
+$24.5M |
| 4 |
ACHN
Achillion Pharmaceuticals
ACHN
|
+$13.7M |
| 5 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
+$2.27M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 45.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMDZ
1
DELISTED
Immune Design Corp.
IMDZ
| $83M | 42.05% |
+2,695,757
| New | +$74.9M |
|
|
EGRX
2
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $73.5M | 37.25% |
+4,741,187
| New | +$60.5M |
|
|
AGRX
3
DELISTED
Agile Therapeutics
AGRX
| $23.7M | 12% |
+1,928
| New | +$24.5M |
|
|
ACHN
4
DELISTED
Achillion Pharmaceuticals
ACHN
| $13.8M | 6.97% |
+1,122,957
| New | +$13.7M |
|
|
ANTH
5
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
| $1.98M | 1% |
+156,250
| New | +$2.27M |
|
6
Savara
SVRA
$1.17B
| $1.43M | 0.72% |
+36,455
| New | +$1.27M |
|
Similar funds
CLA
HC
SF
SCM
DIV
MGPI
MCAI
P